News

Tanner et al. out on Brain

Jeremy Tanner explores the relationship between various PET modalities (amyloid, tau and FDG), and cognition (episodic memory, semantic memory, language, executive function and visuospatial domains), both in early and late-onset Alzheimer's Disease.

Malpetti et al. out on The Journal of Nuclear Medicine

Maura Malpetti compiles evidence of the superiority of tau PET over amyloid PET on estimating cross sectional and longitudinal atrophy measured by MRI, even in heterogeneous samples. Promising data looking forward to individualized precision medicine in the field of dementia.

Chapleau et al. out on The Journal of Nuclear Medicine

Marianne Chapleau provides a review on the application of amyloid PET in neurodegenerative diseases. Comprehensive overview of clinical, pathology and imaging correlates; going through comparisons between PET and fluid biomarkers; and ending on thoughts about application of amyloid PET on clinical...

Windon et al. out on Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Charles Windon led a study comparing CSF and plasma biomarkers across diverse ethnoracial groups (African Americans, Latinos and Non-Hispanic Whites) on ADNI. Brilliant effort to push forward the generalizability of biomarkers in diverse populations!

Mattson-Carlgren et. al. out on Neurology!

An analysis of antemortem CSF from over 100 patients have found an association with neuropathological measures of Aβ, tau, and overall ADNC!

rPOP, PET data-processing script overview published in Neuroimage!

Leonardo Iaccarino has spent quite some time developing a MATLAB-based MRI-free pipeline for implementing non-linear warping and differential smoothing of amyloid-PET scans performed with any of the FDA_approved radiotracers.. and now his toolbox is available to the world!

Strom et al. out on Brain!

Very excited for the study led by our alumna Amelia Strom investigating cortical hypometabolism, local atrophy and tau pathology in symptomatic Alzheimer’s disease to be now published online in Brain!

Rablab @AAIC2021!

Yes, we did it. If you were wondering the RabLab safely joined the AAIC2021 both virtually and physically in Denver. 

Gil Rabinovici's perspective out in NEJM!

Gil Rabinovici's perspective on "Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab" is now published in the New England Journal of Medicine!

Leo interviewed @DementiaMatters

The DementiaMatters podcast interview led by Dr. Nathaniel Chin @Winsconsin ADRC where I (me, Leo, the webmaster!) discuss the findings from our last JAMA Neurology paper was just released, check it out! Also easy to find on Spotify!